Development of Chronic Neutrophilic Leukemia

  • Seo, Byoung-Boo (Dept. of Animal Resources, College of Life & Environmental Science, Daegu University) ;
  • Park, Hum-Dai (Dept. of Biotechnology, College of Engineering, Daegu University)
  • Received : 2011.11.01
  • Accepted : 2011.06.11
  • Published : 2011.12.31

Abstract

The experimental manipulation of protooncogenes and their gene products is a valuable research tool for the study of human neoplasia. In this study, the recently identified human cervical cancer protooncogene (HccR-2) was expressed in transgenic mice under the control of the tetracycline regulatory system. Mice expressing the HccR-2 transgene showed an altered myeloid development characterized by an increased percentage of mature and band-form neutrophils in the peripheral blood, liver and spleen. This phenotype is similar to human chronic neutrophilic leukemia (CNL) in many ways, which is a rare chronic myeloproliferative disorder (CMD) that presents as a sustained leukocytosis of mature neutrophils with a few or no circulating immature granulocytes, an absence of peripheral blood monocytosis, basophilia, or eosinophilia, and an infiltration of neutrophils into the liver, spleen and kidney. Thus, the HccR-2 transgenic mouse model is imperative not only for investigating the biological properties of the HccR-2 protooncogene in vivo, but also for analyzing the mechanisms involved in the progression of CNL.

Keywords

References

  1. Bennet JM, Catovsky D, Daniel M, Flandrin G, Galton D, Gralnic H, Sultan C, Cox C (1994): The chronic myeloid leukaemias: Guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Br J Haematol 87:746-754. https://doi.org/10.1111/j.1365-2141.1994.tb06734.x
  2. Bohm J, Schaefer HE (2002): Chronic neutrophilic leukemia; 14 new cases of an uncommon myeloproliferative disease. J Clin Pathol 55:862-864. https://doi.org/10.1136/jcp.55.11.862
  3. Brigid H, Rosa B, Frank C, Elizabeth L (1994): Manipulating the Mouse Embryo; A Laboratory Manual. SecondEdition. Cold Spring Harbor Laboratory Press. New York, USA pp 217-252.
  4. Di Donato C, Croci G, Lazzari S, Scarduelli L, Vignoli R, Buia M, Tramaloni C, Maccari S, Plancher AC (1986): Chronic neutrophilic leukemia; description of a new case with karyotypic abnormalities. Am J Clin Pathol 85:369-371. https://doi.org/10.1093/ajcp/85.3.369
  5. Elliott MA, Dewald GW, Tefferi A, Hanson C: Chronic neutrophilic leukemia (CNL); a clinical, pathologic and cytogenetic study. Leukemia 2001, 15:35-40. https://doi.org/10.1038/sj.leu.2401993
  6. Fox G, Anderson C, Loew M, Quimby W (2002): Laboratory Animal Medicine. 2nd ed. Academic press. San Diego, USA pp 42-43.
  7. Froberg M, Brunning R, Dorion P, Litz C, Torlakovic E (1998): Demonstration of clonality in neutrophils using FISH in a case of chronic neutrophilic leukemia. Leukemia. 12:623-626. https://doi.org/10.1038/sj.leu.2400938
  8. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller- Hermelink, HK, Vardiman J, Lister T, Bloomfield C (1997): World Health Organisation classification of neoplastic diseases of the haematopoietic and lymphoid tissues; report of the clinical advisory committee meeting- Airlie House. J Clin Oncol 17:3835-3849.
  9. Hiroaki H, Toshiya I, Takahiro S, Hideaki O, Yasuhiro E, Kohichiro T, Tatsutoshi N, Takatoshi I, Yoshio Y, Hisamaru H (1999): Expression of E2A-HLF chimeric protein induced t-cell apoptosis, b-cell maturation arrest and development of acute lymphoblastic leukemia. Blood 93:2780-2790.
  10. Imbert M, Vardiman JW, Bain B: Chronic myeloproliferative diseases. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (2001): World Health Organisation Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARC Press, World Health Organization, USA, pp 20- 28.
  11. Hasle H, Olesen G, Kerndrup G, Philip P, Jacobsen N (1996): Chronic neutrophil leukaemia in adolescence and young adulthood. Br J Haematol 94:628- 630. https://doi.org/10.1046/j.1365-2141.1996.7082329.x
  12. Kojima K, Yasukawa M, Hara M, Nawa Y, Kimura Y, Narumi H, Fujita S (1999): Familial occurrence of chronic neutrophilic leukaemia. Br J Haematol 105: 428-430. https://doi.org/10.1111/j.1365-2141.1999.01348.x
  13. Kwong YL, Cheng G (1993): Clonal nature of chronic neutrophilic leukemia. Blood 82:1035-1036.
  14. Lee JW, Park JH, Kim KS, Ryoo ZY (2003): Vasopressin- SV40 T antigen expression in transgenic mice induces brain tumor and lymphoma. Biochem Biophys Res Commun 302:785-792. https://doi.org/10.1016/S0006-291X(03)00225-0
  15. Matano S, Nakamura S, Kobayashi K, Yoshida T, Matsuda T, Sugimoto T (1997): Deletion of the long arm of chromosome 20 in a patient with chronic neutrophilic leukemia; cytogenetic findings in chronic neutrophilic leukemia. Am J Hematol 54: 72-75. https://doi.org/10.1002/(SICI)1096-8652(199701)54:1<72::AID-AJH11>3.0.CO;2-C
  16. Meyer S, Feremans W, Cantiniaux B, Capel P, Huygen K, Dicato M (1993): Successful alpha-2b-interferon therapy for chronic neutrophilic leukemia. Am J Hematol 43:307-309. https://doi.org/10.1002/ajh.2830430416
  17. Orazi A, Cattoretti G, Sozzi G (1989): A case of chronic neutrophilic leukemia with trisomy 8. Acta Haematol 81:148-151. https://doi.org/10.1159/000205548
  18. Pane F, Frigeri F, Sindona M, Luciano L, Ferrara F, Cimino R, Meloni G, saglio G, Salvatore F, Rotoli B (1996): Neutrophilic-chronic myeloid leukemia; a distinct disease with a specific molecular marker. Blood 88:2410-2414.
  19. Relly JT (2002): Chronic neutrophilic leukemia; A distinct clinical entity? Br J Hematol 116:10-18. https://doi.org/10.1046/j.1365-2141.2002.03234.x
  20. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T (1992): Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693-699. https://doi.org/10.1038/359693a0
  21. Standen GR, Jasani B, Wagstaff M, Wardrop CA (1990): Chronic neutrophilic leukemia and multiple myeloma. An association with lambda light chain expression. Cancer 66:162-166. https://doi.org/10.1002/1097-0142(19900701)66:1<162::AID-CNCR2820660129>3.0.CO;2-Z
  22. Standen GR, Steers FJ, Jones L (1993): Clonality of chronic neutrophilic leukaemia associated with myeloma; analysis using the X-linked probe M27 beta. J Clin Pathol 46:297-298. https://doi.org/10.1136/jcp.46.4.297
  23. Storek J (1992): Chronic neutrophilic leukemia; case report documenting the absence of bcr-abl rearrangement. Am J Hematol 41: 304-308.
  24. Tuohy EL (1920): A case of splenomegaly with polymorphonuclear neutrophil hyperleukocytosis. Am J Med Sci 160: 18-25. https://doi.org/10.1097/00000441-192007000-00003
  25. Yanagisawa K, Ohminami H, Sato M, Takada K, Hasegawa H, Yasukawa M, Fujita S (1998): Neoplastic involvement of granulocytic lineage, not granulocytic- monocytic, monocytic, or erythrocytic lineage, in a patient with chronic neutrophilic leukemia. Am J Hematol 57:221-224. https://doi.org/10.1002/(SICI)1096-8652(199803)57:3<221::AID-AJH7>3.0.CO;2-X
  26. You W, Weisbrot IM (1979):Chronic neutrophilic leukemia; Report of two cases and review of the literature. Am J Clin Pathol 72:233-242. https://doi.org/10.1093/ajcp/72.2.233